Gesynta Pharma
Developer of pharmaceutical drug candidates designed to target inflammation by inhibiting the enzyme mPGES for the precise treatment of inflammatory conditions. The company creates novel anti-inflamma...
Valuation
$0
Share Price
N/A
Total Raised
$61.6M
Last Round
N/A